Embracing the future of document authoring in pharma: a structured and data-driven approach

In the fast-paced world of pharmaceuticals, the clarity and precision of documentation are not just a matter of compliance, but a cornerstone of innovation and patient safety. Structured content plays a critical role in meeting the stringent regulatory demands and the quest for efficiency. The shift towards structured content authoring is revolutionizing the way we think about, produce, and utilize our documents.  At GPRAS 2023 in Brussels, Jan Benedictus presented how this change can propel us towards a future where accuracy is a given, speed to market is accelerated, and the potential for innovation is boundless. In the session called ‘Writing with machines, a view on document automation and collaboration’, he pointed out that the industry is moving away from unstructured formats like PDF to structured documents that are more aligned with current technological capabilities, including generative AI.